Oyster Point Pharma, Inc. OYST Stock
11.17 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
299.85M USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Oyster Point Pharma, Inc. Price Chart
Oyster Point Pharma, Inc. OYST Financial and Trading Overview
| Oyster Point Pharma, Inc. stock price | 11.17 USD |
| Previous Close | 11.17 USD |
| Open | 11.16 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 1000 |
| Day's Range | 11.12 - 11.2 USD |
| 52 Week Range | 3.46 - 12.98 USD |
| Volume | 2.09M USD |
| Avg. Volume | 430.87K USD |
| Market Cap | 299.85M USD |
| Beta (5Y Monthly) | 0.999123 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.6 USD |
OYST Valuation Measures
| Enterprise Value | 216.26M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.5460317 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.389117 |
| Price/Book (mrq) | 2.1195445 |
| Enterprise Value/Revenue | 6.772 |
| Enterprise Value/EBITDA | -1.533 |
Trading Information
Oyster Point Pharma, Inc. Stock Price History
| Beta (5Y Monthly) | 0.999123 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 12.98 USD |
| 52 Week Low | 3.46 USD |
| 50-Day Moving Average | 11.07 USD |
| 200-Day Moving Average | 7.32 USD |
OYST Share Statistics
| Avg. Volume (3 month) | 430.87K USD |
| Avg. Daily Volume (10-Days) | 275.16K USD |
| Shares Outstanding | 26.84M |
| Float | 8.7M |
| Short Ratio | 17.27 |
| % Held by Insiders | 1.53% |
| % Held by Institutions | 88.69% |
| Shares Short | 1.69M |
| Short % of Float | 11.92% |
| Short % of Shares Outstanding | 6.29% |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -442.47% |
| Gross Margin | 90.07% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -57.83% |
| Return on Equity (ttm) | -193.85% |
Income Statement
| Revenue (ttm) | 31.94M USD |
| Revenue Per Share (ttm) | 1.21 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 23.01M USD |
| EBITDA | -141035008 USD |
| Net Income Avi to Common (ttm) | -157568000 USD |
| Diluted EPS (ttm) | -3.114 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 104.88M USD |
| Total Cash Per Share (mrq) | 3.91 USD |
| Total Debt (mrq) | 94.14M USD |
| Total Debt/Equity (mrq) | 873.71 USD |
| Current Ratio (mrq) | 4.263 |
| Book Value Per Share (mrq) | 5.27 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -140820000 USD |
| Levered Free Cash Flow (ttm) | -79064128 USD |
Profile of Oyster Point Pharma, Inc.
| Country | United States |
| State | NJ |
| City | Princeton |
| Address | 202 Carnegie Center |
| ZIP | 08540 |
| Phone | 609 382 9032 |
| Website | https://www.oysterpointrx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 303 |
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.
Q&A For Oyster Point Pharma, Inc. Stock
What is a current OYST stock price?
Oyster Point Pharma, Inc. OYST stock price today per share is 11.17 USD.
How to purchase Oyster Point Pharma, Inc. stock?
You can buy OYST shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oyster Point Pharma, Inc.?
The stock symbol or ticker of Oyster Point Pharma, Inc. is OYST.
Which industry does the Oyster Point Pharma, Inc. company belong to?
The Oyster Point Pharma, Inc. industry is Biotechnology.
How many shares does Oyster Point Pharma, Inc. have in circulation?
The max supply of Oyster Point Pharma, Inc. shares is 26.84M.
What is Oyster Point Pharma, Inc. Price to Earnings Ratio (PE Ratio)?
Oyster Point Pharma, Inc. PE Ratio is 0.00000000 now.
What was Oyster Point Pharma, Inc. earnings per share over the trailing 12 months (TTM)?
Oyster Point Pharma, Inc. EPS is 0 USD over the trailing 12 months.
Which sector does the Oyster Point Pharma, Inc. company belong to?
The Oyster Point Pharma, Inc. sector is Healthcare.
Oyster Point Pharma, Inc. OYST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}